Bank of New York Mellon’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
135,034
-31,120
| -19% | -$316K | ﹤0.01% | 2929 |
|
|
2025
Q1 | $927K | Sell |
166,154
-1,145
| -0.7% | -$6.39K | ﹤0.01% | 3097 |
|
|
2024
Q4 | $1.35M | Buy |
167,299
+129
| +0.1% | +$1.04K | ﹤0.01% | 2947 |
|
|
2024
Q3 | $1.71M | Sell |
167,170
-19,314
| -10% | -$198K | ﹤0.01% | 2826 |
|
|
2024
Q2 | $1.32M | Buy |
186,484
+71,394
| +62% | +$505K | ﹤0.01% | 3031 |
|
|
2024
Q1 | $1.58M | Sell |
115,090
-3,589
| -3% | -$49.3K | ﹤0.01% | 2895 |
|
|
2023
Q4 | $1.09M | Buy |
118,679
+4,029
| +4% | +$37.1K | ﹤0.01% | 3135 |
|
|
2023
Q3 | $694K | Buy |
114,650
+551
| +0.5% | +$3.33K | ﹤0.01% | 3373 |
|
|
2023
Q2 | $885K | Buy |
114,099
+100,790
| +757% | +$782K | ﹤0.01% | 3263 |
|
|
2023
Q1 | $75.9K | Hold |
13,309
| – | – | ﹤0.01% | 4114 |
|
|
2022
Q4 | $78.4K | Hold |
13,309
| – | – | ﹤0.01% | 4163 |
|
|
2022
Q3 | $43K | Hold |
13,309
| – | – | ﹤0.01% | 4343 |
|
|
2022
Q2 | $60K | Sell |
13,309
-97,131
| -88% | -$438K | ﹤0.01% | 4319 |
|
|
2022
Q1 | $590K | Sell |
110,440
-2,249
| -2% | -$12K | ﹤0.01% | 3613 |
|
|
2021
Q4 | $1.66M | Buy |
112,689
+1,875
| +2% | +$27.6K | ﹤0.01% | 3109 |
|
|
2021
Q3 | $2.32M | Buy |
110,814
+28,995
| +35% | +$606K | ﹤0.01% | 2897 |
|
|
2021
Q2 | $1.45M | Buy |
81,819
+5,032
| +7% | +$89.1K | ﹤0.01% | 3199 |
|
|
2021
Q1 | $1.88M | Buy |
76,787
+3,056
| +4% | +$74.9K | ﹤0.01% | 2955 |
|
|
2020
Q4 | $2.5M | Buy |
73,731
+51,147
| +226% | +$1.73M | ﹤0.01% | 2711 |
|
|
2020
Q3 | $564K | Sell |
22,584
-122
| -0.5% | -$3.05K | ﹤0.01% | 3432 |
|
|
2020
Q2 | $766K | Buy |
+22,706
| New | +$766K | ﹤0.01% | 3253 |
|